ClinicalTrials.Veeva

Menu

Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy (GENETIC)

U

University of Aberdeen

Status

Enrolling

Conditions

Takotsubo Cardiomyopathy

Treatments

Genetic: Blood collection for genetic analysis

Study type

Interventional

Funder types

Other

Identifiers

NCT04513054
2-025-18

Details and patient eligibility

About

Acute stress-induced (takotsubo) cardiomyopathy or broken heart syndrome presents like a heart attack, classically is triggered by intense emotional or physical stress and can have serious health consequences. In the current study the investigators wish to establish whether there is a genetic predisposition making certain people more susceptible to this condition. This could also have implications for their families.

Full description

Acute stress-induced (takotsubo) cardiomyopathy presents like a myocardial infarct, is triggered by intense emotional or physical stress, and can have catastrophic and potentially fatal consequences. Despite data linking takotsubo cardiomyopathy with conditions that have a recognized genetic predisposition (such as mental health and neurological problems), a systematic and comprehensive characterisation of the genetic-epidemiologic factors in takotsubo is lacking. The researchers propose to further investigate this disorder by collecting blood from probands and characterising the genotype of patients with takotsubo cardiomyopathy in a large scale, nationwide genome wide association study. The investigators will also archive DNA for identification of future candidate genetic variants. Ultimately, understanding the underlying predisposition of this poorly understood neuro-psycho-cardiac disorder is essential if we are to move this field forward.

Enrollment

700 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients who have been diagnosed with Takotsubo cardiomyopathy in Scotland between 2010 to date.
  • Familial cases elsewhere in the world who would be willing to participate.

Exclusion criteria

  • Unwillingness to participate

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

700 participants in 1 patient group

Takotsubo Case Arm
Other group
Description:
A patient that has been diagnosed with Takotsubo Cardiomyopathy from 2010 onwards.
Treatment:
Genetic: Blood collection for genetic analysis

Trial contacts and locations

1

Loading...

Central trial contact

Amelia E Rudd, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems